The SCA17 phenotype can include features of MSA-C, PSP and cognitive impairment

Parkinsonism and Related Disorders

Volumn 13, Issue 4, 2007, Pages 246-249

  Lin, I Sheng ^a   Wu, Ruey Meei ^a   Lee Chen, Guey Jen ^b   Shan, Din E ^c   Gwinn Hardy, Katrina ^d  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN NORMAL UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

MSA; PSP; SCA17; Taiwanese; TATA box binding protein (TBP)

Indexed keywords

6 FLUORODOPA; BENSERAZIDE PLUS LEVODOPA; BUSPIRONE; CARBIDOPA PLUS LEVODOPA; ROPINIROLE;

ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COGNITIVE DEFECT; DIFFERENTIAL DIAGNOSIS; GENETIC ASSOCIATION; HUMAN; MALE; PARKINSONISM; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SHY DRAGER SYNDROME; SPINOCEREBELLAR ATAXIA 17; SPINOCEREBELLAR DEGENERATION; STRIATONIGRAL DEGENERATION;

BRAIN; COGNITION DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY; SPINOCEREBELLAR ATAXIAS; TATA BOX; TATA-BOX BINDING PROTEIN; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 34247117930     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2006.04.009     Document Type: Article

References (9)

1. Everett C.M., and Wood N.W. Trinucleotide repeats and neurodegenerative disease. Brain 127 (2004) 2385-2405
2. Koide R., Kobayashi S., Shimohata T., Ikeuchi T., Maruyama M., Saito M., et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?. Human Mol Genet 8 (1999) 2047-2053
3. Zuhlke C., Hellenbroich Y., Dalski A., Kononowa N., Hagenah J., Vieregge P., et al. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Human Genet 9 (2001) 160-164
4. Nakamura K., Jeong S.Y., Uchihara T., Anno M., Nagashima K., Nagashima T., et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Human Mol Genet 10 (2001) 1441-1448
5. Fujigasaki H., Martin J.J., De Deyn P.P., Camuzat A., Deffond D., Stevanin G., et al. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain 124 (2001) 1939-1947
6. Rolfs A., Koeppen A.H., Bauer I., Bauer P., Buhlmann S., Topka H., et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol 54 (2003) 367-375
7. Burk K., Skalej M., and Dichgans J. Pontine MRI hyperintensities ("the cross sign") are not pathognomonic for multiple system atrophy (MSA). Mov Disord 16 (2001) 535
8. Wu Y.R., Lin H.Y., Chen C.M., Gwinn-Hardy K., Ro L.S., Wang Y.C., et al. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease. Clin Genet 65 (2004) 209-214
9. Zuhlke C., Gehlken U., Hellenbroich Y., Schwinger E., and Burk K. Phenotypical variability of expanded alleles in the TATA-binding protein gene. Reduced penetrance in SCA17?. J Neurol 250 (2003) 161-163